Program Director (Head)
Description
Cornerstone Search Group has been retained by one of the world’s leading medical research philanthropic foundations to identify a PhD scientist with pharmaceutical / biotech / VC experience in Business Development for their newly-created Program Director leadership position that will partner closely with the foundation’s CSO to proactively identify, select, disburse, and manage a large portfolio of “big bets” (multi-million dollar awards) on Principal Investigators conducting exceptionally innovative drug and diagnostic translational research that can fundamentally change a field of medicine or healthcare delivery.
Founded by an American billionaire, this foundation’s mission is to proactively identify and fund “high-risk/high-return” and “first in field” projects, rather than relying on the typical “call for proposal” process depended upon by more conventional funders in the biomedical research ecosystem. This foundation (and this position) actively “hunts” for breakthrough therapeutics and diagnostics that might be "stuck" in a lab because it is too expensive to manufacture or too risky for traditional VC firms and provides the "catalytic capital" to prove it works in human patients. The foundation’s awards are “non-dilutive”, meaning that no intellectual property stake is ever requested back from the university or faculty recipients.
The metrics of success are deaths averted, FDA approvals of diagnostics and therapeutics, number of changes in the standards of care/year, and paradigm-changing new mechanistic knowledge for treating human disease.
The metrics of success are deaths averted, FDA approvals of diagnostics and therapeutics, number of changes in the standards of care/year, and paradigm-changing new mechanistic knowledge for treating human disease.
FOUNDATION’S AREAS OF MEDICAL FOCUS:
The foundation’s multiple Scientific Advisory Boards align with the following areas of focus:
- Regenerative medicine / stem cell therapies
- Life-threatening pediatric diseases
- Cancer - focus on undruggable targets and early detection
- Autism spectrum disorders
- Sepsis
- CV/Stroke
Location
TRAVEL: Up to 25% in order to attend national research meetings, pre- and post-award PI site visits, and special research meetings
LOCATION: Greater Atlanta Metro Area
- housing costs literally half of the Greater Boston area and much lower real estate taxes
- shorter winters with temperatures in the 50s and little if any snow
RELOCATION: Relocation assistance is available.
Features
4 Highly Attractive Features:
- High-Profile Impact: How often in your career will you have the opportunity to hunt and fund early-stage translational medical research with "game changing" potential that might otherwise go unfunded due to the pharma industry and VCs considering the bets too risky?
- Wide Range of Modalities & TAs: Unlike working in BD at a small biotech, or in BD for one therapeutic area at a large pharma, here you’ll exercise your scientific curiosity across a wide range of cutting-edge modalities in 6 disease areas.
- Best of Both Worlds: Enjoy the most attractive aspects of industry/VC business development and alliance management without industry downsides (i.e., making deals based on financial gain rather than on significant patient unmet need | layoffs | lack of funding | hardball negotiating | getting outbid by deeper pockets)
- Career Stability: The foundation’s endowment is in the multiple billions, ensuring a career long runway. In this era of pharma industry instability and staff cutbacks by companies of all sizes, having the peace of mind to work for an organization whose finances do not depend on external funding and patent expirations is priceless.
Responsibilities
Position Scope in a Nutshell:
- Report to the CSO, a highly respected physician-scientist with excellent communication skills, who is looking for this position to be a true partner.
- Partner with the CSO, the foundation’s multiple Scientific Advisory Board Committees, and agentic AI to scout for mostly unpublished and newly published potential new projects.
- Coordinate rapid external expert peer reviews using “best practices” funding methods developed at DARPA, NIH, and large disease research specific foundations.
- Partner with the CSO to identify, select, and recruit additional new expert peer reviewers to join their various Scientific Advisory Board Committees.
- Represent the foundation at national research meetings.
- In conjunction with the SABs, provide strategic “portfolio progress” advice to the CSO on potential additional funding partners (e.g., NIH, DoD, NSF, CDC, biomedical research-intensive foundations, and biopharma companies) to leverage additional investigations where it appears meritorious. Side-by-side partnerships with biopharmas are encouraged.
- Monitor research award performance goals against milestones, publications, and budget alignment to ensure investigators fulfill research award requirements.
- Oversee the daily administration and data management of the foundation’s portfolio.
- Manage a Data Manager who is responsible for ensuring that all documentation is organized and tracked.
Qualifications / Requirements
DESIRED SKILLS / QUALIFICATIONS / EXPERIENCES / BEHAVIORS:
- Prior pharma/biotech/VC industry business development experience (e.g., JVs, M&A), particularly with early-stage R&D identification and acquisition. Additional alliance management experience is a plus.
- PhD in life sciences with bench laboratory experience
- A publication record with some original peer-reviewed research that employs molecular biology
- Strong entrepreneurial spirit
- Boundless intellectual curiosity
- Proactive self-starter with an urgency to deliver new solutions to life threatening diseases.
- A relationship builder who can forge strong bonds with academic researchers, funding partners in other foundations, and stakeholders in universities, government, and biopharmas.
- Strong planning, project management, and process improvement skills with the bandwidth to juggle multiple programs and projects simultaneously.
THESE ARE PLUSES, BUT NOT REQUIRED:
- Research background in immunology, neuroscience, cell biology, pharmacology, or microbiology
- Experience with the design, conduct, and reporting of IRB-approved clinical trials in diagnostics or therapeutics or population sciences.
- Experience within teams that were successful in grant writing with organizations such as the NCI, NIH, DoD, NSF, VA, CDC, biomedical research foundations, health care systems, or relevant federal and state agencies.
- Demonstrated relationships with public agencies or private foundations that fund medical research.
- Experience in biomedical research projects within, or in partnership with, the NIH, CDC, VA, or FDA.
Contact
Recently Completed Retained Searches by Cornerstone
REPRESENTATIVE RETAINED SEARCH ASSIGNMENTS:- CEO | specialty pharma start-up
- CEO | regenerative medicine start-up
- US CEO | established European small pharma
- President/US Commercial Head | Generics Pharma
- CMO | late-stage public biotech
- CMO | mid-size pharma
- CSO | mid-size global biotech
- SVP, Head of Global Medical Affairs | mid-size oncology company
- SVP, Head of Global Clinical Development | multi-TA mid-size pharma
- SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
- Global Head, Oncology R&D | mid-size European pharma
- Group VP, Global Commercial Head | API Business Unit | Indian pharma
- VP, Data Science RWE | Top 5 Pharma
- VP, Head of Regulatory Affairs | Boston Biotech
- VP, US Head of Regulatory Affairs | Top 20 Pharma
- VP, Head of R&D Operations | Boston biotech
- VP, Head of Business Development | mid-size European Oncology pharma
- VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma
- VP, Head of US HEOR & RWE | Top 5 Pharma
- VP, Head of Real-World Evidence | Top 5 pharma
- VP, Head of US HEOR | Top Oncology Pharma
- ED, Head of HEOR | Top West Coast Pharma
- VP, Head of Global Market Access | Top Oncology Specialty Pharma
- VP, Head of US Market Access | High-profile late-stage biotech
- VP, Head of US Market Access | West Coast Late-Stage Public Biotech
- VP, Head of Heme/Onc Clinical Research | Public oncology biotech
- VP, Head of Clinical Development | late-stage anti-infectives UK pharma
- VP, Head of Global Drug Safety & PV | Chinese oncology biotech
- ED, Head of Clinical Operations | British VC-backed biotech
- ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
- ED, Head of Global Clinical Pharmacology | Public oncology biotech
- Head, Patient Advocacy | European commercial-stage rare disease biotech
Cornerstone's Privacy Policy
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.